anti-programmed cell death protein 1 immunotherapyimmunotherapypembrolizumabMerkel cell carcinomaskin cancerMCC
…ite limited evidence regarding the treatment of metastatic MCC, anti-programmed cell death protein 1 immunotherapy has emerged as a primary strategy for managing advanced stages …